CN Patent
CN102600109B — 一种右兰索拉唑迟释胶囊及其制备方法
Assigned to Joy Pharmaceutical Technology Co., Ltd. · Expires 2014-09-17 · 12y expired
What this patent protects
本发明属于药物制剂技术领域,具体涉及一种右兰索拉唑迟释胶囊及其制备方法,该胶囊内装有两种微丸,第一种微丸与第二种微丸所含右兰索拉唑的质量比为1:3-4。本发明的右兰索拉唑迟释胶囊可以避免右兰索拉唑在胃酸中被破坏,并在肠道中定位释放,以达到起效迅速,提高生物利用度的目的。
USPTO Abstract
本发明属于药物制剂技术领域,具体涉及一种右兰索拉唑迟释胶囊及其制备方法,该胶囊内装有两种微丸,第一种微丸与第二种微丸所含右兰索拉唑的质量比为1:3-4。本发明的右兰索拉唑迟释胶囊可以避免右兰索拉唑在胃酸中被破坏,并在肠道中定位释放,以达到起效迅速,提高生物利用度的目的。
Drugs covered by this patent
- Dexilant (DEXLANSOPRAZOLE) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.